BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23093209)

  • 1. Cell uptake survey of pegylated nanographene oxide.
    Vila M; Portolés MT; Marques PA; Feito MJ; Matesanz MC; Ramírez-Santillán C; Gonçalves G; Cruz SM; Nieto A; Vallet-Regi M
    Nanotechnology; 2012 Nov; 23(46):465103. PubMed ID: 23093209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-biointeractions of PEGylated and bare reduced graphene oxide on lung alveolar epithelial cells: A comparative in vitro study.
    Reshma SC; Syama S; Mohanan PV
    Colloids Surf B Biointerfaces; 2016 Apr; 140():104-116. PubMed ID: 26741270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of size and dose on the biodistribution of graphene oxide in mice.
    Liu JH; Yang ST; Wang H; Chang Y; Cao A; Liu Y
    Nanomedicine (Lond); 2012 Dec; 7(12):1801-12. PubMed ID: 22830500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxicity of PEGylated graphene oxide on lymphoma cells.
    Du L; Wu S; Li Y; Zhao X; Ju X; Wang Y
    Biomed Mater Eng; 2014; 24(6):2135-41. PubMed ID: 25226911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positively charged graphene oxide nanoparticle: precisely label the plasma membrane of live cell and sensitively monitor extracellular pH in situ.
    Zhu H; Gao L; Jiang X; Liu R; Wei Y; Wang Y; Zhao Y; Chai Z; Gao X
    Chem Commun (Camb); 2014 Apr; 50(28):3695-8. PubMed ID: 24575428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice.
    Yang K; Wan J; Zhang S; Zhang Y; Lee ST; Liu Z
    ACS Nano; 2011 Jan; 5(1):516-22. PubMed ID: 21162527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene.
    Li Y; Feng L; Shi X; Wang X; Yang Y; Yang K; Liu T; Yang G; Liu Z
    Small; 2014 Apr; 10(8):1544-54. PubMed ID: 24376215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy metabolism analysis reveals the mechanism of inhibition of breast cancer cell metastasis by PEG-modified graphene oxide nanosheets.
    Zhou T; Zhang B; Wei P; Du Y; Zhou H; Yu M; Yan L; Zhang W; Nie G; Chen C; Tu Y; Wei T
    Biomaterials; 2014 Dec; 35(37):9833-9843. PubMed ID: 25212524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
    Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the lateral dimension of graphene oxide in the regulation of cellular responses.
    Yue H; Wei W; Yue Z; Wang B; Luo N; Gao Y; Ma D; Ma G; Su Z
    Biomaterials; 2012 Jun; 33(16):4013-21. PubMed ID: 22381473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration.
    Yang K; Gong H; Shi X; Wan J; Zhang Y; Liu Z
    Biomaterials; 2013 Apr; 34(11):2787-95. PubMed ID: 23340196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gold nanorod-assembled PEGylated graphene-oxide nanocomposites for photothermal cancer therapy.
    Dembereldorj U; Choi SY; Ganbold EO; Song NW; Kim D; Choo J; Lee SY; Kim S; Joo SW
    Photochem Photobiol; 2014; 90(3):659-66. PubMed ID: 24303894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy.
    Yang HW; Lu YJ; Lin KJ; Hsu SC; Huang CY; She SH; Liu HL; Lin CW; Xiao MC; Wey SP; Chen PY; Yen TC; Wei KC; Ma CC
    Biomaterials; 2013 Sep; 34(29):7204-14. PubMed ID: 23800742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power.
    Yang K; Wan J; Zhang S; Tian B; Zhang Y; Liu Z
    Biomaterials; 2012 Mar; 33(7):2206-14. PubMed ID: 22169821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Size-dependent cell uptake of protein-coated graphene oxide nanosheets.
    Mu Q; Su G; Li L; Gilbertson BO; Yu LH; Zhang Q; Sun YP; Yan B
    ACS Appl Mater Interfaces; 2012 Apr; 4(4):2259-66. PubMed ID: 22409495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro study of single and four layer graphene oxide nanoflakes - Cytotoxicity and cellular uptake.
    Peruzynska M; Cendrowski K; Barylak M; Tkacz M; Piotrowska K; Kurzawski M; Mijowska E; Drozdzik M
    Toxicol In Vitro; 2017 Jun; 41():205-213. PubMed ID: 28323107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uniform ultrasmall graphene oxide nanosheets with low cytotoxicity and high cellular uptake.
    Zhang H; Peng C; Yang J; Lv M; Liu R; He D; Fan C; Huang Q
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1761-7. PubMed ID: 23402618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyethylene glycol and octa-arginine dual-functionalized nanographene oxide: an optimization for efficient nucleic acid delivery.
    Imani R; Prakash S; Vali H; Faghihi S
    Biomater Sci; 2018 May; 6(6):1636-1650. PubMed ID: 29757340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular imaging with a graphene-based fluorescent probe.
    Peng C; Hu W; Zhou Y; Fan C; Huang Q
    Small; 2010 Aug; 6(15):1686-92. PubMed ID: 20602429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors controlling the size of graphene oxide sheets produced via the graphite oxide route.
    Pan S; Aksay IA
    ACS Nano; 2011 May; 5(5):4073-83. PubMed ID: 21469697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.